Question 1

What is the catalog number for EFNA2 Antibody Blocking Peptide?

Accepted Answer

The catalog number for EFNA2 Antibody Blocking Peptide is orb1500267.

Question 2

What sizes are available for EFNA2 Antibody Blocking Peptide?

Accepted Answer

EFNA2 Antibody Blocking Peptide is available in the following size(s): 500 µg.

Question 3

Is EFNA2 Antibody Blocking Peptide in stock?

Accepted Answer

EFNA2 Antibody Blocking Peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is EFNA2 Antibody Blocking Peptide used for?

Accepted Answer

This product is EFNA2 Antibody Blocking Peptide. It targets Ephrin-A2. Purification is performed using HPLC.

Question 5

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 6

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

EFNA2 Antibody Blocking Peptide

Product Specifications

Product Name Alternative

Field of Research

Storage Conditions

Notes

Frequently Asked Questions

Explore Other Products

PRIC285 Antibody

PRIC285 Antibody

PRIC285 Antibody

Biotinylated Anti-CD73 (oleclumab biosimilar) mAb

Biotinylated Anti-CD73 (oleclumab biosimilar) mAb

Biotinylated Anti-CD73 (oleclumab biosimilar) mAb